News - Merck & Co, Amgen

Filter

Current filters:

Merck & CoAmgen

Popular Filters

ASBMR 2012: Anabolics and post-marketing studies

25-10-2012

This year's American Society for Bone and Mineral Research (ASBMR) conference, held in Minneapolis, Minnesota,…

AmgenAnti-Arthritics/RheumaticsBiotechnologyEli LillyMerck & CoodanacatibPharmaceuticalProliaResearchteriparatideUnigene Labs

New data on Amgen's Prolia and Merck & Co's odanacatib presented at ASBMR meeting

15-10-2012

Amgen (Nasdaq: AMGN), the world's largest biotech firm, has presented data from several Prolia (denosumab)…

AmgenAnti-Arthritics/RheumaticsBiotechnologyMerck & CoodanacatibPharmaceuticalProliaResearchWomen's Health

More news briefs from ASH meeting

14-12-2011

In ongoing news from the American Society of Hematology (ASH) meeting taking place in San Diego, Swiss…

AmgenBiotechnologydaratumumabExjadeGenmabMerck & CoNovartisNplateOncologyPharmaceuticalResearchZolinza

Back to top